ethical implications of opportunistic detection of melanoma in clinical care (2023)

Article Navigation

Volume 188 Issue 6 June 2023
  • < Previous
  • Next >

Journal Article

Get access

Catherine M Olsen,

Catherine M Olsen

Cancer Control Group

Faculty of Medicine, The University of Queensland

,

Queensland

,

Australia

Correspondence: Catherine M. Olsen. Email: Catherine.Olsen@qimrberghofer.edu.au

Search for other works by this author on:

Oxford Academic

Louisa G Gordon,

Louisa G Gordon

Faculty of Medicine, The University of Queensland

,

Queensland

,

Australia

Health Economics Group, QIMR Berghofer Medical Research Institute

,

Queensland

,

Australia

Queensland University of Technology (QUT), School of Nursing, Institute of Health and Biomedical Innovation

,

Brisbane, Queensland

,

Australia

Search for other works by this author on:

Oxford Academic

Stacy M Carter, David C Whiteman

David C Whiteman

Cancer Control Group

Faculty of Medicine, The University of Queensland

,

Queensland

,

Australia

Search for other works by this author on:

Oxford Academic

British Journal of Dermatology, Volume 188, Issue 6, June 2023, Pages 798–799, https://doi.org/10.1093/bjd/ljad055

Published:

03 March 2023

Article history

Received:

27 October 2022

Revision received:

21 February 2023

Accepted:

28 February 2023

Published:

03 March 2023

Corrected and typeset:

18 April 2023

  • Views
    • Article contents
    • Figures & tables
    • Video
    • Audio
    • Supplementary Data
  • Cite

    Cite

    Catherine M Olsen and others, The ethical implications of opportunistic detection of melanoma in clinical care, British Journal of Dermatology, Volume 188, Issue 6, June 2023, Pages 798–799, https://doi.org/10.1093/bjd/ljad055

    Close

Search

Close

Search

Advanced Search

Search Menu

Extract

https://doi.org/10.1093/bjd/ljad055

Population-based screening for melanoma is not currently recommended because there is insufficient evidence that the benefits outweigh the harms.1 Instead, early detection mostly takes place opportunistically, via skin checks offered or requested in a doctor–patient encounter. This has led to a notable rise in the detection of in situ and thin melanomas, without a proportionate decrease in incidence of thicker melanomas or a decline in melanoma mortality. This appears to provide evidence for overdiagnosis (the detection of cancers through screening that would not have caused significant morbidity or mortality within a person’s lifetime).2 Given this, we sought to appraise the ethical implications of opportunistic detection of melanoma.

The accepted criteria for evaluating screening programmes include that screening should be beneficial to both individuals and to the community, and that harms should be minimized or avoided.3 In population-based cancer screening programmes (e.g. breast, colorectal), a policy is developed and implemented after explicitly accounting for the balance of benefits and harms. In contrast, for opportunistic cancer detection (e.g. prostate, skin), the decision whether or not to screen is made by thepractitioner and patient. Evaluating the balance of benefits and harms of melanoma detection is challenging because no randomized screening trials have been conducted, and thus population-level data on potential benefits or harms are lacking. We recognize that widespread opportunistic melanoma detection approximates population screening, such that an ethics analysis utilizing concepts, values and principles of public health ethics analysis would be valuable. However, because skin checks currently occur in the context of individual doctor–patient clinical encounters, we focus on the ethical implications using Beauchamp and Childress’s principles of clinical medical ethics: beneficence, nonmaleficence, autonomy, and justice.4

Issue Section:

Perspectives

You do not currently have access to this article.

Download all slides

Sign in

Get help with access

Personal account

  • Sign in with email/username & password
  • Get email alerts
  • Save searches
  • Purchase content
  • Activate purchases and trials

Sign in Register

Institutional access

  1. Sign in through your institution ethical implications of opportunistic detection of melanoma in clinical care (9)
  2. Sign in with a library card Sign in with username / password Recommend to your librarian

Institutional account management

Sign in as administrator

Get help with access

Institutional access

Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:

IP based access

Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.

Sign in through your institution

Choose this option to get remote access when outside your institution. Shibboleth / Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.

  1. Click Sign in through your institution.
  2. Select your institution from the list provided, which will take you to your institution's website to sign in.
  3. When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
  4. Following successful sign in, you will be returned to Oxford Academic.

If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.

Sign in with a library card

Enter your library card number to sign in. If you cannot sign in, please contact your librarian.

Society Members

Society member access to a journal is achieved in one of the following ways:

Sign in through society site

Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:

  1. Click Sign in through society site.
  2. When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
  3. Following successful sign in, you will be returned to Oxford Academic.

If you do not have a society account or have forgotten your username or password, please contact your society.

Sign in using a personal account

Some societies use Oxford Academic personal accounts to provide access to their members. See below.

Personal account

A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.

Some societies use Oxford Academic personal accounts to provide access to their members.

Viewing your signed in accounts

Click the account icon in the top right to:

  • View your signed in personal account and access account management features.
  • View the institutional accounts that are providing access.

Signed in but can't access content

Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.

Institutional account management

For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.

Purchase

Subscription prices and ordering for this journal

Purchasing options for books and journals across Oxford Academic

Short-term Access

To purchase short-term access, please sign in to your personal account above.

Don't already have a personal account? Register

The ethical implications of opportunistic detection of melanoma in clinical care - 24 Hours access

EUR €55.00

GBP £48.00

USD $59.00

Rental

ethical implications of opportunistic detection of melanoma in clinical care (10)

This article is also available for rental through DeepDyve.

Advertisement intended for healthcare professionals

Citations

Views

66

Altmetric

More metrics information

×

Email alerts

Article activity alert

Advance article alerts

New issue alert

Receive exclusive offers and updates from Oxford Academic

Citing articles via

Google Scholar

  • Latest

  • Most Read

  • Most Cited

Visualising complexity: embracing graphical abstracts in the BJD
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: A cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
The skin of people experiencing homelessness: more (known) is less (neglected)
Editor's Choice – John Ingram June 2023
Results from 1 year of treatment with lebrikizumab for atopic dermatitis

More from Oxford Academic

Clinical Medicine

Dermatology

Medicine and Health

Books

Journals

Advertisement intended for healthcare professionals

Top Articles
Latest Posts
Article information

Author: Nicola Considine CPA

Last Updated: 20/05/2023

Views: 6155

Rating: 4.9 / 5 (69 voted)

Reviews: 92% of readers found this page helpful

Author information

Name: Nicola Considine CPA

Birthday: 1993-02-26

Address: 3809 Clinton Inlet, East Aleisha, UT 46318-2392

Phone: +2681424145499

Job: Government Technician

Hobby: Calligraphy, Lego building, Worldbuilding, Shooting, Bird watching, Shopping, Cooking

Introduction: My name is Nicola Considine CPA, I am a determined, witty, powerful, brainy, open, smiling, proud person who loves writing and wants to share my knowledge and understanding with you.